中国继续医学教育
中國繼續醫學教育
중국계속의학교육
China Continuing Medical Education
2015年
24期
152-153
,共2页
尼莫地平%川芎嗪%脑血管功能不全%疗效对比
尼莫地平%川芎嗪%腦血管功能不全%療效對比
니막지평%천궁진%뇌혈관공능불전%료효대비
Nimodipine%TMP%Cerebral vascular insufficiency%Comparative efifcacy
目的:研究对慢性脑血管功能不全患者行尼莫地平联合川芎嗪治疗的临床效果。方法选取我院确诊的慢性脑血管功能不全患者60例,随机分为实验组和对照组两组,各30例,对照组单纯给予口服尼莫地平进行治疗;实验组在此基础上联合静脉滴注丹参川芎嗪注射液治疗,治疗期1个月,对治疗后两组患者的疗效和不良反应发生情况予以对比分析。结果治疗后实验组总有效率达到96.67%(29/30),高于对照组的73.33%(22/30),两组比较差异具有统计学意义(P<0.05);实验组不良反应发生率为6.67%(2/30),对照组不良反应发生率为10%(3/30),两组比较差异无统计学意义(P>0.05)。结论对慢性脑血管功能不全患者行尼莫地平联合川芎嗪治疗临床疗效显著,安全可靠,临床实用价值高。
目的:研究對慢性腦血管功能不全患者行尼莫地平聯閤川芎嗪治療的臨床效果。方法選取我院確診的慢性腦血管功能不全患者60例,隨機分為實驗組和對照組兩組,各30例,對照組單純給予口服尼莫地平進行治療;實驗組在此基礎上聯閤靜脈滴註丹參川芎嗪註射液治療,治療期1箇月,對治療後兩組患者的療效和不良反應髮生情況予以對比分析。結果治療後實驗組總有效率達到96.67%(29/30),高于對照組的73.33%(22/30),兩組比較差異具有統計學意義(P<0.05);實驗組不良反應髮生率為6.67%(2/30),對照組不良反應髮生率為10%(3/30),兩組比較差異無統計學意義(P>0.05)。結論對慢性腦血管功能不全患者行尼莫地平聯閤川芎嗪治療臨床療效顯著,安全可靠,臨床實用價值高。
목적:연구대만성뇌혈관공능불전환자행니막지평연합천궁진치료적림상효과。방법선취아원학진적만성뇌혈관공능불전환자60례,수궤분위실험조화대조조량조,각30례,대조조단순급여구복니막지평진행치료;실험조재차기출상연합정맥적주단삼천궁진주사액치료,치료기1개월,대치료후량조환자적료효화불량반응발생정황여이대비분석。결과치료후실험조총유효솔체도96.67%(29/30),고우대조조적73.33%(22/30),량조비교차이구유통계학의의(P<0.05);실험조불량반응발생솔위6.67%(2/30),대조조불량반응발생솔위10%(3/30),량조비교차이무통계학의의(P>0.05)。결론대만성뇌혈관공능불전환자행니막지평연합천궁진치료림상료효현저,안전가고,림상실용개치고。
Objective Research on chronic cerebral vascular insufifciency patients TMP nimodipine therapy clinical results. Methods A total of 60 patients with chronic cerebrovascular insufifciency were randomly divided into the experimental group and the control group of two groups, each of 30 cases, control group were given oral nimodipine treatment;experimental group on the basis of joint Salvia TMP intravenous injection therapy, treatment of one month, to be analyzed for efficacy and adverse reactions after two groups of occurrence. Results After the experimental treatment group, the total efifciency of 96.67%(29/30), signiifcantly higher than the 73.33%(22/30), the difference was statistically signiifcant (P<0.05), incidence of adverse reactions in the experimental group 6.67%(2/30), the occurrence of adverse events in the control group was 10%(3/30), no signiifcant difference (P>0.05) groups. Conclusion Chronic cerebral vascular insufifciency patients nimodipine TMP clinical effect is signiifcant, safe, reliable, high clinical value.